Anti-human TROP-2 antibody having anti-tumor activity in vivo

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9670287
APP PUB NO 20160053018A1
SERIAL NO

14729953

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides: an antibody, which specifically reacts with hTROP-2 and has anti-tumor activity in vivo; a hybridoma, which produces the aforementioned antibody; a complex of the aforementioned antibody and a drug; a pharmaceutical composition for diagnosing or treating a tumor; a method for detecting a tumor; and a kit for detecting or diagnosing a tumor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHIOME BIOSCIENCE INCTOKYO 151-0071

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kanke, Toru Kanagawa, JP 14 91
Nakamura, Koji Tokyo, JP 269 3092
Okamura, Kentaro Kanagawa, JP 11 137
Tamura, Maki Kanagawa, JP 12 90
Yanai, Hiroyuki Kanagawa, JP 23 254

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00